Zap Surgical Systems, Inc.

Based in the US, Zap Surgical Systems, Inc. is an innovative medical technology company specializing in advanced radiosurgery solutions for cranial treatments, designed to enhance patient accessibility and treatment precision. Zap Surgical Systems, Inc. , founded in 2014 in San Carlos, California, US, focuses on developing advanced radiosurgery technologies.

The company has raised a total of USD 78. 00 mn through its funding rounds, including a recent Series E funding of USD 78. 00 mn led by Baheal Pharmaceutical Group on November 8, 2024. CEO John Adler has been instrumental in guiding the company's direction and growth.

ZAP Surgical Systems, Inc. specializes in advanced medical technology through its flagship product, the ZAP-X® Gyroscopic Radiosurgery® platform. This system revolutionizes cranial stereotactic radiosurgery by eliminating the need for high-cost radiation bunkers, making SRS accessible in various healthcare facilities, including outpatient and rural hospitals. The ZAP-X platform utilizes advanced linear accelerator technology to deliver precise non-coplanar radiation, minimizing non-therapeutic exposure and facilitating future re-treatments.

Since its launch in 2017, ZAP Surgical has catered to neurosurgeons and radiation oncologists, aiming to provide quality care across international markets, including the US, Japan, and the European Union. ZAP Surgical generates revenue through the sale of its ZAP-X Gyroscopic Radiosurgery platform and associated services. The company engages in direct sales and partnerships with healthcare institutions, allowing for the integration of ZAP-X systems into treatment offerings. The revenue model includes one-time equipment sales along with ongoing support and maintenance agreements, ensuring continuous service and technology updates.

The company also offers specialized training and planning services to clients, enhancing the value of its technology while fostering long-term relationships with healthcare providers. In November 2024, Zap Surgical Systems, Inc. raised USD 78. 00 mn in Series E funding, which will be utilized to commercialize its pioneering ZAP-X® gyroscopic radiosurgery platform.

The company aims to expand its offerings and penetrate new markets globally, focusing on increasing accessibility to its advanced radiosurgery solutions. Specific plans for new product designs or launches have not been detailed, but the recent funding will support the company's initiatives to enhance its technological capabilities and market reach.